New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Johnson & Johnson
JNJ
Shape
US Flag

NYSE

354B

Drug Manufacturers - General

Next Earning date - 22 Jan 2025

354B

Drug Manufacturers - General

Next Earning date - 22 Jan 2025

147.03USD
Shape-0.74 ( -0.50%)
Market Open
favorite-chart

Relative Strenght

18
favorite-chart

Volume Buzz

-5%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

13%

Quote Panel

Shape
Updated January 19, 2025
1W 1.77 % 1M 1.77 % 3M -8.98 % 1Y -6.64 %

Key Metrics

Shape
  • Market Cap

    353.99B


  • Shares Outstanding

    2.41B


  • Share in Float

    2.40B


  • Dividende

    4.91


  • Earning Date

    22 Jan 2025


  • Price Target

    147.03


  • Average Volume

    7.81M


  • Beta

    0.518


  • Range

    140.68-168.85


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.jnj.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

JNJ

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$91B

Shape306%

2025-Revenue

$10.56

Shape843%

2025-EPS

$31B

Shape461%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Johnson Rice

downgrade

Previous: Overweight

2024-07-23

Now: Neutral

Johnson Rice

upgrade

Previous: Overweight

2024-04-18

Now: Buy

Johnson Rice

upgrade

Previous: Overweight

2024-04-18

Now: Negative

Wells Fargo

downgrade

Previous: Overweight

2023-12-28

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+10%

2.35
vs 2.13

Q2.23

arrow
arrow

+0%

2.68
vs 2.67

Q3.23

arrow
arrow

+8%

2.8
vs 2.59

Q4.23

arrow
arrow

+4%

2.66
vs 2.55

Q4.23

arrow
arrow

-10%

2.29
vs 2.55

Q1.24

arrow
arrow

+15%

2.71
vs 2.35

Q2.24

arrow
arrow

+5%

2.82
vs 2.68

Q3.24

arrow
arrow

-14%

2.42
vs 2.8

Q4.24

arrow
arrow

-11%

2.03
vs 2.29

Q1.25

arrow
arrow

-1%

2.68
vs 2.71

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-4%

23.7B  vs 24.8B

Q2.23

arrow
arrow

-11%

20.9B  vs 23.4B

Q3.23

arrow
arrow

-10%

21.5B  vs 24B

Q4.23

arrow
arrow

+7%

21.4B  vs 20B

Q4.23

arrow
arrow

+7%

21.4B  vs 20B

Q1.24

arrow
arrow

-10%

21.4B  vs 23.7B

Q2.24

arrow
arrow

+7%

22.4B  vs 20.9B

Q3.24

arrow
arrow

+4%

22.5B  vs 21.5B

Q4.24

arrow
arrow

+5%

22.4B  vs 21.4B

Q1.25

arrow
arrow

+3%

22B  vs 21.4B

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+5%

0.05
vs 0.06

Q2.23

arrow
arrow

0%

-0.00
vs 0.05

Q3.23

arrow
arrow

+7%

0.07
vs -0.00

Q4.23

arrow
arrow

+37%

0.37
vs 0.07

Q4.23

arrow
arrow

+6%

0.06
vs 0.37

Q1.24

arrow
arrow

+5%

0.05
vs 0.06

Q2.24

arrow
arrow

+7%

0.07
vs 0.05

Q3.24

arrow
arrow

+4%

0.04
vs 0.07

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

3870

3.9K
vs 3.7K

5%

Q1.23

arrow
arrow

3803

3.8K
vs 3.9K

-2%

Q2.23

arrow
arrow

3825

3.8K
vs 3.8K

1%

Q3.23

arrow
arrow

3742

3.7K
vs 3.8K

-2%

Q4.23

arrow
arrow

3931

3.9K
vs 3.7K

5%

Q1.24

arrow
arrow

3900

3.9K
vs 3.9K

-1%

Q2.24

arrow
arrow

3853

3.9K
vs 3.9K

-1%

Q3.24

arrow
arrow

3922

3.9K
vs 3.9K

2%

Earnings Growth

Latest News